Topical Glycopirrolate for the Management of Hyperhidrosis in Herpetic Neuralgia by Ladjevic, Nebojsa Gojko & Likic-Ladjevic, Ivana Spasoje
Yonsei Med J    http://www.eymj.org     Volume 50    Number 2    April 2009 293
Herpes zoster is a relapse of varicella. The disease manifests itself through skin changes,
itching and pain in the area of one or more proximate spinal or cranial nerves. Its presence
in the ophthalmic branch of the N. trigeminus is manifested as herpes zoster ophtalmicus.
Complications on the skin can develop as superinfections, most frequently with strepto-
staphylococcus, such as conjunctivitis, uveitis or keratitis. In certain cases, long-term pain
and hyperhidrosis have been observed. The appearance of herpes zoster during pregnancy
is not a frequent occurrence.
1 We describe the treatment of hyperhidrosis and pain using
glycopyrrolate cream in a pregnant woman diagnosed with herpetic neuralgia.
A 32 year old woman, 21 weeks pregnant with second child, complained to her gynecologist
of the appearance of a vesicular rash on the left half of the forehead that progressed toward
her left eyelid. Three days prior to the appearance of skin changes prodromal symptoms
appeared in the form of general weakness, an occipital headache, sensation of increased
body temperature and a mild itch in the affected dermatome. When skin changes appeared,
they were accompanied by increased body temperature (37.5˚C), itching, a high intensity
burning and lancinating pain, allodynia, hyperhidrosis, and small edema. Clinically
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the first division of the fifth cranial (trigeminal) nerve. Besides
skin changes, the eye was affected by blepharitis and conjunc-
tivitis. Following clinical examination, the clinical diagnosis
was established as herpes zoster with virological confirmation
of the clinical diagnosis. Patient had herpes zoster for the first
time. In view of the expansion of the herpes zoster toward the
left eye, Aciclovir therapy was initiated immediately, 800 mg
orally five times daily for seven days, with skin treatment with
cool compresses and mechanical cleansing. Aciclovir therapy
was initiated 50 hours following the appearance of the first
symptoms and 5 hours after the patient came in for examina-
tion. Blepharitis treatment was palliative with cool compresses,
topical lubrication, and a topical broad-spectrum antibiotic as
prevention for secondary bacterial infection (usually Staphylo-
coccus aureus). The patient received out-patient care with daily
review. Four days following initial examination, the patient
complained of pain in the area of the dermatome which was
becoming more intense and unpleasant, preventing normal
sleep and everyday functioning. The patient defined the
intensity of the pain according to the Visual Analogue Scale
(VAS scale). At that moment it was equal to 5.5 (moderate pain).
Pain therapy was initiated with amitriptyline 12.5 mg at night.
The dose was increased to 25 mg after 3 days. According to the
VAS scale, the pain ranged between 3 to 4 (3.5) during this
therapy. Basic therapy cured the skin changes, but did not
terminate the pain. We discontinued amitriptyline therapy after
10 days because of the appearance of unwanted side effects:
sedation, dry mouth, constipation. Following the curing of skin
changes which lasted 2 weeks, the lancinating pain remained
accompanied by hyperhidrosis in the dermatoma zone,
especially after meals. The intensity of the remaining pain was
between 3 to 4 (3.5) according to the VAS scale. After curing
the skin changes we introduced Lidocaine patch 5%. The
patient used the patch for one week. Topical Lidocain reduced
the allodynia, but not the lancinating pain (still 3.5) and the
hyperhidrosis. At that time, we introduced glycopyrrolate
cream. Glycopirrolate cream 1% in thin layers was applied in
the area of the tender skin on the forehead and within 24 hours
it reduced the intensity of the pain by 28.5% (VAS=2.5; mild
pain), and completely cured the hyperhidrosis. After 48 hours
of use the pain therapy continued for another 7 days and was
then discontinued. The pain and the hyperhidrosis did not
reappear, there were no side effects during he glicopirrolate
cream therapy. 
Herpes zoster can develop at any age, but the highest incidence
is after 50 years. Overall, it occurs in 20% of the population
with more than one recurrence in 4%.
2 The rash of zoster is
often intensely pruritic and spreads throughout the dermatome,
evolving through papular, vesicular and crusting stages. It
usually lasts two to four weeks. The most troubling symptom is
usually pain, which ranges from mild to severe and from burning
to lancinating. Paraesthesiae, or anaesthesia and allodynia (pain
induced by touch, often from trivial stimuli) can accompany
severe pain. The pain may be self-limited or persist beyond the
rash for up to a year (“postherpetic neuralgia”). Another
relatively common complication is herpes zoster ophthalmicus
(2-4%), which follows fifth cranial (trigeminal) nerve first
division. It ranges from keratitis to more severe iritis.
3 Herpes
zoster during pregnancy is not associated with intrauterine
infection. It is usually mild in this age group and viraemia is
uncommon unless the woman is immunocompromised. Prior to
the appearance of the herpes zoster virus (HZV), our patient
was subjected to stress due to a death in the family. Given that
our patient came to our clinic within two days of the onset of
the disease, with a case of ophthalmic zoster which was
confirmed in laboratory tests, we decided to initiate Aciclovir
therapy which is recommended in cases like this as it does not
lead to unwanted side effects in the mother and the unborn
child. Virus isolation by culture is the laboratory gold standard
and works best when lesions are fresh and moist. Systemic
antiviral therapy is able to shorten the healing process of acute
herpes zoster, to prevent or to alleviate pain and other acute and
chronic complications, particularly when given within 48 hours
to a maximum of 72 hours after onset of the rash. Systemic
antiviral therapy is urgently indicated in patients beyond the age
of 50 years and in patients at any age with herpes zoster in the
head and neck area, especially in patients with zoster ophthal-
micus.
4 We used antiviral therapy after 50 hours from the
appearance of the disease. Aciclovir therapy yielded good
results, although the severe and persistent pain in the area of the
affected dermatome required the introduction of new medica-
tion. We use combined therapy with small doses of Amitriptyline
administered orally, which is most often used for herpetic pain,
but in combination with Lidocaine patch.
5 The appearance of
unwanted side effects persistent pain and the hyperhidrosis led
us to the idea of attempting Glycopirrolate cream 1% which is
easily applied to the skin and removed with water. Glycopirro-
late cream used in Frey’s syndrome proved to be excellent in
hyperhidrosis therapy.
6 Findings indicate the disappearance of
pain. Also it was very interesting noticing that pain and sweating
disappeared simultaneously. We think that Glycopirrolate had
blocking effect at muscarinic receptors and local nerves.
Goldstein findings suggest facial pain and sweating resulting
from occupation of muscarinic cholinergic receptors after
acetylcholine release from local nerves.
7 Ulus found higher
serum choline levels in pregnant.
8 Choline is a precursor for
phosphatidylcholine, acetylcholine biosynthesis and a methyl
donor. Drummond suggests that irritating the eye induces a
trigeminal-parasympathetic vasodilator reflex and local
sweating.
9 Our patient had strong eye irritation by zoster
ophtalmicus. Finally, this is first report to document that topical
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Glycopirrolate cream has a beneficial effect in a patient with
hyperhidrosis and herpetic neuralgia.
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